grant
saveAQUALUNG THERAPEUTICS CORP. — Targeting eNAMPT-TLR4 signaling with the novel ALT-100 mAb to slow IPF progre...
September 20, 2025updated 5mo ago
community read0 votes
HL grant. $284,699. PI: Stanley Miele
view source ↗Data sources
last refreshed 5mo ago
Found something off?
comments(0)
5-min edit window · permanent after that